SPYRE THERAPEUTICS, INC. Shares Outstanding (Cover Page)
SPYRE THERAPEUTICS, INC. (SYRE) had Shares Outstanding (Cover Page) of 88.17 million shares as of 2026-07-28, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-28: Entity Common Stock, Shares Outstanding 88.17M shares.
- 2026-04-28: Entity Common Stock, Shares Outstanding 86.84M shares.
- 2026-02-12: Entity Common Stock, Shares Outstanding 78.54M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 77.59M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-28 | 88.17M shares 10-Q · filed 2026-08-04 |
| 2026-04-28 | 86.84M shares 10-Q · filed 2026-05-05 |
| 2026-02-12 | 78.54M shares 10-K · filed 2026-02-19 |
| 2025-10-29 | 77.59M shares 10-Q · filed 2025-11-04 |
| 2025-07-31 | 60.40M shares 10-Q · filed 2025-08-05 |
| 2025-05-02 | 60.35M shares 10-Q · filed 2025-05-08 |
| 2025-02-19 | 60.28M shares 10-K · filed 2025-02-27 |
| 2024-11-01 | 51.43M shares 10-Q/A · filed 2024-11-18 |
| 2024-08-01 | 50.79M shares 10-Q/A · filed 2024-11-18 |
| 2024-05-01 | 40.28M shares 10-Q/A · filed 2024-11-18 |
| 2024-02-21 | 36.15M shares 10-K/A · filed 2024-11-18 |
| 2023-11-03 | 4.05M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 101.19M shares 10-Q · filed 2023-08-11 |
| 2023-05-02 | 65.40M shares 10-Q · filed 2023-05-11 |
| 2023-02-21 | 65.40M shares 10-K · filed 2023-03-02 |
| 2022-10-28 | 61.51M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 61.17M shares 10-Q · filed 2022-08-04 |
| 2022-04-28 | 50.42M shares 10-Q · filed 2022-05-05 |
| 2022-02-24 | 49.36M shares 10-K · filed 2022-03-08 |
| 2021-10-28 | 49.32M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 49.06M shares 10-Q · filed 2021-08-05 |
| 2021-05-05 | 49.02M shares 10-Q · filed 2021-05-10 |
| 2021-03-12 | 48.02M shares 10-K · filed 2021-03-18 |
| 2020-11-02 | 47.94M shares 10-Q · filed 2020-11-05 |
| 2020-08-05 | 44.60M shares 10-Q · filed 2020-08-10 |
| 2020-05-01 | 44.59M shares 10-Q · filed 2020-05-07 |
| 2020-02-20 | 29.09M shares 10-K · filed 2020-02-24 |
| 2019-11-01 | 28.99M shares 10-Q · filed 2019-11-06 |
| 2019-08-01 | 28.89M shares 10-Q · filed 2019-08-06 |
| 2019-05-01 | 28.85M shares 10-Q · filed 2019-05-07 |
| 2019-03-01 | 28.82M shares 10-K · filed 2019-03-07 |
| 2018-11-02 | 23.96M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 22.00M shares 10-Q · filed 2018-08-09 |
| 2018-05-04 | 21.86M shares 10-Q · filed 2018-05-08 |
| 2018-03-08 | 16.72M shares 10-K · filed 2018-03-13 |
| 2017-11-03 | 16.64M shares 10-Q · filed 2017-11-07 |
| 2017-08-07 | 16.45M shares 10-Q · filed 2017-08-09 |
| 2017-05-08 | 13.45M shares 10-Q · filed 2017-05-09 |
| 2017-03-23 | 13.45M shares 10-K · filed 2017-03-23 |
| 2016-11-09 | 13.43M shares 10-Q · filed 2016-11-09 |
| 2016-08-08 | 13.41M shares 10-Q · filed 2016-08-09 |
| 2016-05-19 | 13.41M shares 10-Q · filed 2016-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |